Abstract
Religiosity and spirituality predict lower alcohol and other substance use in community samples of adolescents and adults. However, the roles of religiosity and spirituality in substance use have not been examined in individuals with cystic fibrosis (CF). Adults with CF (n = 123) completed measures of spirituality, religiosity, and substance use. Clinical measures of illness severity (e.g., BMI and %FEV1) were obtained from participants’ medical records. Substance use rates for alcohol, tobacco, and marijuana were lower in this sample than those seen in the general population. Of the measured BMMRS subscales, spiritual experiences and religious commitment were significant predictors of lower alcohol use. These results suggest that personal factors of religiosity and spirituality are more important for substance use in adults with CF than participation in religious service and events or adoption of religious practices.
Similar content being viewed by others
Abbreviations
- CF:
-
Cystic fibrosis
- BMI:
-
Body mass index
- FEV1 :
-
Forced expiratory volume in 1 s
- CFTR:
-
Cystic fibrosis transmembrane conductance regulator
- CFRD:
-
Cystic fibrosis-related diabetes
- BMMRS:
-
Brief Multidimensional Measure of Religiosity/Spirituality
References
Aldwin, C. M., Park, C. L., Jeong, Y.-J., & Nath, R. (2014). Differing pathways between religiousness, spirituality, and health: a self-regulation perspective. Psychol Relig Spirit, 6(1), 9.
Bagaitkar, J., Demuth, D. R., & Scott, D. A. (2008). Tobacco use increases susceptibility to bacterial infection. Tob induc dis, 4(1), 12.
Bilton, D. (2008). Cystic fibrosis. Medicine, 36(5), 273–278.
Britto, M. T., Garrett, J. M., Dugliss, M. A., Daeschner, C., Johnson, C. A., Leigh, M. W., et al. (1998). Risky behavior in teens with cystic fibrosis or sickle cell disease: a multicenter study. Pediatrics, 101(2), 250–256.
Chitwood, D. D., Weiss, M. L., & Leukefeld, C. G. (2008). A systematic review of recent literature on religiosity and substance use. J Drug Issues, 38(3), 653–688.
Collaco, J. M., Vanscoy, L., Bremer, L., McDougal, K., Blackman, S. M., Bowers, A., et al. (2008). Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease. JAMA, 299(4), 417–424.
Cystic Fibrosis Foundation. (2016). Cystic Fibrosis Foundation Patient Registry. 2015 Annual Data Report. In: (pp. 4-90): Cystic Fibrosis Foundation Bethesda, MD.
Ferkol, T., Rosenfeld, M., & Milla, C. E. (2006). Cystic fibrosis pulmonary exacerbations. The Journal of pediatrics, 148(2), 259–264.
Fetzer Institute. (2003). Multidimensional measurement of religiousness, spirituality for use in health research: A report of a national working group supported by the Fetzer Institute in collaboration with the National Institute on Aging In (pp. 1-96): John E. Fetzer Institute Kalamazoo, MI.
Geppert, C., Geppert, C., Bogenschutz, M. P., Geppert, C., Bogenschutz, M. P., & Miller, W. R. (2007). Development of a bibliography on religion, spirituality and addictions. Drug Alcohol Rev, 26(4), 389–395.
Hall, W., & Degenhardt, L. J. T. L. (2009). Adverse health effects of non-medical cannabis use. Lancet, 374(9698), 1383–1391.
Kelly, A., & Moran, A. (2013). Update on cystic fibrosis-related diabetes. Journal of Cystic Fibrosis, 12(4), 318–331.
Maléth, J., Balázs, A., Pallagi, P., Balla, Z., Kui, B., Katona, M., et al. (2015). Alcohol disrupts levels and function of the cystic fibrosis transmembrane conductance regulator to promote development of pancreatitis. Gastroenterology, 148(2), 427–439.
Maras, D., Balfour, L., Tasca, G. A., Gaudet, E., Aaron, S. D., Cameron, W. D., et al. (2019). Breathlessness catastrophizing relates to poorer quality of life in adults with cystic fibrosis. Journal of Cystic Fibrosis, 18(1), 150–157.
Marsiglia, F. F., Ayers, S. L., & Hoffman, S. (2012). Religiosity and adolescent substance use in Central Mexico: exploring the influence of internal and external religiosity on cigarette and alcohol use. Am J Commun Psychol, 49(1–2), 87–97.
McEwan, F. A., Hodson, M. E., & Simmonds, N. J. (2012). The prevalence of “risky behaviour” in adults with cystic fibrosis. Journal of Cystic Fibrosis, 11(1), 56–58.
Mitmansgruber, H., Smrekar, U., Rabanser, B., Beck, T., Eder, J., & Ellemunter, H. (2016). Psychological resilience and intolerance of uncertainty in coping with cystic fibrosis. Journal of Cystic Fibrosis, 15(5), 689–695.
Mohr, C., Armeli, S., Tennen, H., Carney, M. A., Affleck, G., & Hromi, A. (2001). Daily interpersonal experiences, context, and alcohol consumption: crying in your beer and toasting good times. Journal of Personality and Social Psychology, 80(3), 489.
Mohr, C., Armeli, S., Tennen, H., & Todd, M. (2010). The complexities of modeling mood-drinking relationships: Lessons learned from daily process research.
Moran, A., Brunzell, C., Cohen, R. C., Katz, M., Marshall, B. C., Onady, G., et al. (2010). linical care guidelines for cystic fibrosis–related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care, 33(12), 2697–2708.
Orens, J. B., Estenne, M., Arcasoy, S., Conte, J. V., Corris, P., Egan, J. J., et al. (2006). International guidelines for the selection of lung transplant candidates: 2006 update—a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. The Journal of heart and lung transplantation, 25(7), 745–755.
O’Sullivan, B. P., & Freedman, S. D. (2009). Cystic fibrosis. The Lancet, 373(9678), 1891–1904.
Rubin, B. K. (1990). Exposure of children with cystic fibrosis to environmental tobacco smoke. New Engl J Med, 323(12), 782–788.
Smyth, A., O’Hea, U., Williams, G., Smyth, R., & Heaf, D. (1994). Passive smoking and impaired lung function in cystic fibrosis. Archives of Disease in Childhood, 71(4), 353–354.
Stern, R. C., Byard, P. J., Tomashefski, J. F., Jr., & Doershuk, C. F. (1987). Recreational use of psychoactive drugs by patients with cystic fibrosis. Journal of Pediatrics, 111(2), 293–299.
Tashkin, D. P. (2013). Effects of marijuana smoking on the lung. Ann Am Thorac Soc, 10(3), 239–247.
Tetrault, J. M., Crothers, K., Moore, B. A., Mehra, R., Concato, J., & Fiellin, D. A. (2007). Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Archives of Internal Medicine, 167(3), 221–228.
Tucker, J. S., Ellickson, P. L., Orlando, M., Martino, S. C., & Klein, D. J. (2005). Substance use trajectories from early adolescence to emerging adulthood: a comparison of smoking, binge drinking, and marijuana use. J Drug Issues, 35(2), 307–332.
Williams, D. R., & Sternthal, M. J. (2007). Spirituality, religion and health: evidence and research directions. Med J Aust, 186(10), S47.
Yonker, J. E., Schnabelrauch, C. A., & DeHaan, L. G. (2012). The relationship between spirituality and religiosity on psychological outcomes in adolescents and emerging adults: a meta-analytic review. J Adolescence, 35(2), 299–314.
Acknowledgement
This work was supported by the UAB Center for Palliative and Supportive Care. This funding source had no involvement in: study design, collection, analysis and interpretation of data, writing of the report, or the decision to submit the article for publication.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
There are no known conflicts of interest for any of the authors who contributed to this work
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Burgess, B.E., Mrug, S., Bray, L.A. et al. Predicting Substance Use from Religiosity/Spirituality in Individuals with Cystic Fibrosis. J Relig Health 60, 1818–1831 (2021). https://doi.org/10.1007/s10943-020-01119-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10943-020-01119-z